Using traditional HTAs to determine coverage threatens patient access to medicine

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
Traditional HTAs keep diverse patients out of the conversation

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
Traditional HTA methods treat everyone like the “average” patient

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...
Read More
Potential gene therapies bring hope to patients with sickle cell disease

A recent analysis highlights how potential gene therapies have the potential to dramatically reduce income disparities for patients with sickle cell disease, leading to as much as $21,000 more in...
Read More
Stephanie Dyson of BMS on reducing health disparities

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...
Read More
Sharing rebates can save Americans with diabetes $500 each year and improve adherence, especially for Black and Hispanic Americans

A new study by GlobalData looked at brand oral antidiabetic drugs (OADs) and found that sharing negotiated rebates with patients in commercial health plans at the pharmacy counter can help lower...
Read More
Announcing CAREs Grant Round 4

Medicines can be critical to treating, managing, and sometimes curing illnesses, thereby offering an effective tool to improve health outcomes and reduce health disparities. However, numerous studies...
Read More
Guest Series: PhRMA talks racial and health equity with Lauren Powell, VP US Health Equity and Community Wellness, Takeda

Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
Read More
As part of PhRMA’s continuing commitment to build a more just and equitable health care system, we recently awarded $75,000 through our Collaborative Actions to Reach Equity (CAREs) grant program to...
Read More